TITLE

Toxoplasma seropositivity and depression: a case report

AUTHOR(S)
Kar, Nilamadhab; Misra, Baikunthanath
PUB. DATE
January 2004
SOURCE
BMC Psychiatry;2004, Vol. 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Background: The association between toxoplasmosis and psychiatric disorders has been reported in a few anecdotal reports. Case Presentation: A case of depression with toxoplasma seropositivity is presented. The patient with depression showed poor response to antidepressants, for which he was investigated and was found positive on the serological test for the toxoplasma. The response to antidepressant treatment improved only after adequate treatment for toxoplasma. Conclusions: The case suggests a probable association between toxoplasmosis and depression.
ACCESSION #
29323642

 

Related Articles

  • Depression: How Medicine Can Help.  // American Family Physician;3/1/2000, Vol. 61 Issue 5, special section p1 

    Reveals how medicine can help depression, a mental illness like diabetes or high blood pressure. Causes of depression; Treatment for depression; Things considered by doctor before choosing antidepressant medicine for depressed persons; Different kinds of antidepressants.

  • Repetitive Transcranial Magnetic Stimulation: Does it Have Potential in the Treatment of Depression? Padberg, Frank; Möller, Hans-Jürgen // CNS Drugs;2003, Vol. 17 Issue 6, p383 

    Transcranial magnetic stimulation (TMS) has become a major research tool in experimental clinical neurophysiology as a result of its potential to noninvasively and focally stimulate cortical brain regions. Currently, studies are being conducted to investigate whether repetitive TMS...

  • Economic Implications of Treatment-Resistant Depression Among Employees. Greenberg, Paul; Corey-Lisle, Patricia K.; Birnbaum, Howard; Marynchenko, Maryna; Claxton, Ami // PharmacoEconomics;2004, Vol. 22 Issue 6, p363 

    Background: Conservation estimates indicate between 10% and 20% of all individuals with major depressive disorders (MDDs) fail to respond to conventional antidepressant therapies. Amongst those with MDD, individuals with treatment-resistant depression (TRD)have been found to be frequent users of...

  • Canadian study finds that antidepressant use has increased in people with major depression over the past decade. Green, Carla A. // Evidence Based Mental Health;Feb2005, Vol. 8 Issue 1, p26 

    The article focuses on the use of antidepressants among people with major depression in Canada. Antidepressant use is increasing in people with major depression in Canada, particularly in men, unmarried people, and people aged less than 35 years. This appears to be due to changes in practice as...

  • Physical Symptoms Comorbid With Depression and the New Antidepressant Duloxetine. Bailey, Katharine P. // Journal of Psychosocial Nursing & Mental Health Services;Dec2003, Vol. 41 Issue 12, p13 

    Most general descriptions of depression that date back to Hippocrates, including the DSM-IV, have listed gastrointestinal problems, sleep disturbances, headaches, appetite changes, and aches and pains of a diffuse nature as common features of the disorder. In addition, physical symptoms have a...

  • The Chemical Imbalance Hypothesis: An Evaluation of the Evidence. Schultz, William // Ethical Human Psychology & Psychiatry;2015, Vol. 17 Issue 1, p60 

    Powered by philosophic argument, scientific evidence, and multibillion dollar pharmaceutical companies sponsoring multimillion dollar advertising campaigns, the chemical imbalance hypothesis has saturated our academic and popular culture. This saturation is, at least partially, responsible for...

  • Remission is the optimal goal of acute phase antidepressant therapy. Thase, M. E. // Actas Espanolas de Psiquiatria;ene 2008 Supplement 1, Vol. 36, p7 

    The article discusses the significance of considering remission in carrying out acute phase antidepressant therapy. It states that remission refers to the complete recovery of depressed patients from the mental disorder showing enhanced psychosocial and vocational outcomes. According to the...

  • Prediction and prevention of suicide in patients with unipolar depression and anxiety. Gonda, Xenia; Fountoulakis, Konstantinos N; Kaprinis, George; Rihmer, Zoltan // Annals of General Psychiatry;2007, Vol. 6, p23 

    Epidemiological data suggest that between 59 and 87% of suicide victims suffered from major depression while up to 15% of these patients will eventually commit suicide. Male gender, previous suicide attempt(s), comorbid mental disorders, adverse life-situations, acute psycho-social stressors...

  • Antidepressant utilization in Canada. Beck, Cynthia A.; Patten, Scott B.; Williams, Jeanne V. A.; Jian Li Wang; Currie, Shawn R.; Maxwell, Colleen J.; El-Guebaly, Nady // Social Psychiatry & Psychiatric Epidemiology;Oct2005, Vol. 40 Issue 10, p799 

    Objective Antidepressant utilization can be used as an indicator of appropriate treatment for major depression. The objective of this study was to characterize antidepressant utilization in Canada, including the relationships of antidepressant use with sociodemographic variables, past-year and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics